Apotex Corp. recalls
6 recalls filed under Apotex Corp.. The most recent was published October 7, 2026.
-
Class II · 18 days ago
Apotex Corp. Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle recall: Failed dissolution specifications
Failed dissolution specifications.
-
Class II · last month
Apotex Corp. Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle recall: Failed Dissolution Specifications; product failed to meet 24-month stability
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
-
Class II · 6 months ago
Apotex Corp. Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle recall: Defective container: defect in a batch of bottle caps
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
-
Class II · 7 months ago
Apotex Corp. Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 1+ years ago
Apotex Corp. Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL recall: Lack of Assurance of Sterility; atypical weight loss due to improper bottle
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
-
Class II · 1+ years ago
Apotex Corp. Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5% recall: Lack of Assurance of Sterility; atypical weight loss due to improper bottle
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
About this page
Apotex Corp. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.